Natera Q2 FY26: revenue +37.7% to $752.8M, net loss narrows 33.7% to -$67.0M

Filed August 7, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 8, 2025 · ~1 min read

Key Changes

• high

  Net loss narrowed 33.7% to $67.0M (-$0.47 per share) as revenue growth outpaced cost increases; operating loss improved 31% to $75.8M from $110.4M.

  MD&A: Operating Results verify on EDGAR →
• high

  Guardant false-advertising judgment ($292.5M) entered June 2026; Natera is appealing to the Ninth Circuit. ArcherDX damages reduced ~$10M to ~$10.6M, with 30% ongoing royalty imposed.

  Notes: Litigation verify on EDGAR →
• medium

  Foresight Diagnostics acquisition added $141.1M goodwill, $360.2M intangibles, and up to $175M in milestone-based contingent consideration (fair value $120.5M at June 30, 2026).

  Notes: Business Combinations verify on EDGAR →